BeOne Medicines ONC
NASDAQ ONC
$369.06 -5.02 (-1.34%)
At close: Oct 16, 2026 · 4:00 PM EDT

BeOne Medicines (ONC) Selling, General & Administrative (2015 - 2026)

Updated

BeOne Medicines' Selling, General & Administrative was $593.21 million in Q2 2026, up 10.3% from $537.91 million a year earlier and up 6.9% from the prior quarter.

Analysis

BeOne Medicines (ONC) Selling, General & Administrative (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, BeOne Medicines' Selling, General & Administrative was $2.23 billion through Jun 30, 2026, up 14.1% year-over-year; for FY2025, it was $2.08 billion, up 13.7% from FY2024.

  • Selling, General & Administrative has now increased for 11 consecutive years, with a five-year compound annual growth rate of 28.2% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $1.83 billion in FY2024 (+21.4%), $1.51 billion in FY2023 (+17.9%), $1.28 billion in FY2022 (+29.1%) and $990.12 million in FY2021 (+65.0%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2015.
  • Compared with a year earlier, Selling, General & Administrative has increased for 42 straight quarters, with growth averaging 16.4% over the last eight quarters.
  • The year-over-year growth in Selling, General & Administrative has ranged between 7.5% (Q1 2025) and 67.4% (Q3 2021) over the last five years.
  • Per Business Quant data, ONC's Selling, General & Administrative in the three quarters before Q2 2026 was $555.1 million (Q1 2026), $555.29 million (Q4 2025) and $529 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 6.43 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.63 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 5.65 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 1.92 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 3.41 Bn
10 BeOne Medicines 41.22 Bn 22.75 Bn 1.53 Bn 593.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 593.21 Mn
Mar 31, 2026 555.10 Mn
Dec 31, 2025 555.29 Mn
Sep 30, 2025 529.00 Mn
Jun 30, 2025 537.91 Mn
Mar 31, 2025 459.29 Mn
Dec 31, 2024 504.68 Mn
Sep 30, 2024 455.22 Mn
Jun 30, 2024 443.73 Mn
Mar 31, 2024 427.43 Mn
Dec 31, 2023 418.39 Mn
Sep 30, 2023 365.71 Mn
Jun 30, 2023 395.03 Mn
Mar 31, 2023 328.50 Mn
Dec 31, 2022 329.74 Mn
Sep 30, 2022 322.89 Mn
Jun 30, 2022 331.40 Mn
Mar 31, 2022 294.57 Mn
Dec 31, 2021 306.50 Mn
Sep 30, 2021 269.23 Mn
API Access

BeOne Medicines Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ONC&period=max&api_key=YOUR_API_KEY